Please login to the form below

Not currently logged in
Email:
Password:

tadalafil

This page shows the latest tadalafil news and features for those working in and with pharma, biotech and healthcare.

FDA approves Sanofi's follow-on version of Lilly’s Humalog

FDA approves Sanofi's follow-on version of Lilly’s Humalog

Humalog is just one of Lilly’s big brands facing competition, along with erectile dysfunction therapy Cialis (tadalafil) and antiplatelet drug Effient (prasugrel), and the company recently announced sweeping job cuts

Latest news

  • Lilly pilots enhanced online trial information Lilly pilots enhanced online trial information

    The pilot project has so far been added to two clinical trials, a study of Taltz (ixekizumab) in non-radiographic axial spondyloarthritis and one of Cialis (tadalafil) in pediatric patients with

  • GSK earns expanded approval for Volibris in Europe GSK earns expanded approval for Volibris in Europe

    But, the decision is based on data from the phase III/IV AMBITION study, which showed that the combination of Volibris (ambrisentan) and tadalafil reduced the risk of clinical failure by ... 50% in treatment-naïve PAH patients compared to pooled

  • Gilead receives FDA approval for PAH combo Gilead receives FDA approval for PAH combo

    Letairis with tadalafil given the nod for pulmonary arterial hypertension. Gilead has received FDA approval for the use of Letairis in combination with tadalafil for the treatment of pulmonary arterial hypertension. ... The study showed that combination

  • Gilead and GSK pulmonary hypertension drugs work in tandem Gilead and GSK pulmonary hypertension drugs work in tandem

    Ambrisentan is commercialised by Gilead in the US as Letairis and by GSK outside the US as Volibris, while tadalafil is promoted by GSK in Europe for PAH as Adcirca, under ... Combining ambrisentan and tadalafil cut the risk of treatment failure by 50%,

  • Transition takes on Lilly muscle-boosting drug Transition takes on Lilly muscle-boosting drug

    In the past, Lilly has tested SARMs in tandem with its Cialis (tadalafil) drug for erectile dysfunction (ED), while in recent years there has been growing interest in TRT to help

More from news
Approximately 2 fully matching, plus 20 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics